StockData

Drugs Made In America Acquisition II Corp. (DMII) stock

DMIINasdaqBlank ChecksFiscal year ends December 31Also trades as DMIIR, DMIIU
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 16, 2026
$10.23−0.01 (-0.15%)

Close on Nov 18, 2026Market cap $140.15MP/E –Yield –

Drugs Made In America Acquisition II cash

Cash and short-term investments held at the end of each period.

Drugs Made In America Acquisition II's cash was $118.23K at Sep 30, 2026. For fiscal 2025 it was $223, down 98.7% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$223-98.7%
FY2024Dec 31, 2024$17.04K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$118.23K-62.5%
Q2 FY2026Jun 30, 2026$174.97K+3882.1%
Q1 FY2026Mar 31, 2026$347.72K+4873.8%
Q4 FY2025Dec 31, 2025$223-98.7%
Q3 FY2025Sep 30, 2025$315.09K+162.4%
Q2 FY2025Jun 30, 2025$4.39K–
Q1 FY2025Mar 31, 2025$6.99K–
Q4 FY2024Dec 31, 2024$17.04K–
Q3 FY2024Sep 30, 2024$120.07K–

More Drugs Made In America Acquisition II figures

See a number that looks wrong?